Literature DB >> 10913396

Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe, and seasonal.

S B Gordon1, A L Walsh, M Chaponda, M A Gordon, D Soko, M Mbwvinji, M E Molyneux, R C Read.   

Abstract

We prospectively collected laboratory details and outcome data on all patients with laboratory-confirmed cases of meningitis that presented to our unit in Blantyre, Malawi, from 1 April 1998 through 31 March 1999. There were 502 patients with cases of meningitis; the most common causative organisms were Cryptococcus neoformans and Streptococcus pneumoniae. This pattern probably reflects the local human immunodeficiency virus (HIV) seroprevalence (31%) and is different from the pattern in 1974, when Neisseria meningitidis was the most common isolate. There has been an 8-fold increase in the number of meningitis cases per year since 1974, and a doubling of the percentage of medical admissions due to meningitis. The inpatient mortality rate among patients with cases of pneumococcal meningitis was 61%, and in the group as a whole was 41%. Despite the HIV-related pattern of infecting pathogens among these cases of meningitis and the increased incidence of the condition, there was evidence that the typical seasonal pattern of pneumococcal meningitis, which peaks in the cold, dry season, was preserved.

Entities:  

Mesh:

Year:  2000        PMID: 10913396     DOI: 10.1086/313910

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  51 in total

Review 1.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  Cryptococcus neoformans phospholipase B1 activates host cell Rac1 for traversal across the blood-brain barrier.

Authors:  Ravi Maruvada; Longkun Zhu; Donna Pearce; Yi Zheng; John Perfect; Kyung J Kwon-Chung; Kwang Sik Kim
Journal:  Cell Microbiol       Date:  2012-06-26       Impact factor: 3.715

3.  Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfection.

Authors:  Kirsten Nielsen; Gary M Cox; Anastasia P Litvintseva; Eleftherios Mylonakis; Stephanie D Malliaris; Daniel K Benjamin; Steven S Giles; Thomas G Mitchell; Arturo Casadevall; John R Perfect; Joseph Heitman
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Impact of mating type, serotype, and ploidy on the virulence of Cryptococcus neoformans.

Authors:  Xiaorong Lin; Kirsten Nielsen; Sweta Patel; Joseph Heitman
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

5.  Morphine modulation of toll-like receptors in microglial cells potentiates neuropathogenesis in a HIV-1 model of coinfection with pneumococcal pneumoniae.

Authors:  Raini Dutta; Anitha Krishnan; Jingjing Meng; Subash Das; Jing Ma; Santanu Banerjee; Jinghua Wang; Richard Charboneau; Om Prakash; Roderick A Barke; Sabita Roy
Journal:  J Neurosci       Date:  2012-07-18       Impact factor: 6.167

Review 6.  The immunopathogenesis of cryptococcal immune reconstitution inflammatory syndrome: understanding a conundrum.

Authors:  David B Meya; Yukari C Manabe; David R Boulware; Edward N Janoff
Journal:  Curr Opin Infect Dis       Date:  2016-02       Impact factor: 4.915

7.  Cryptococcal meningitis in Senegal: epidemiology, laboratory findings, therapeutic and outcome of cases diagnosed from 2004 to 2011.

Authors:  Doudou Sow; Roger Clément Tine; Khadime Sylla; Mansata Djiba; Cheikh Tidiane Ndour; Thérèse Dieng; Jean Louis Ndiaye; Babacar Faye; Daouda Ndiaye; Oumar Gaye; Yémou Dieng
Journal:  Mycopathologia       Date:  2013-10-25       Impact factor: 2.574

8.  Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa.

Authors:  Matthew Scarborough; Stephen B Gordon; Christopher J M Whitty; Neil French; Yasin Njalale; Alex Chitani; Timothy E A Peto; David G Lalloo; Eduard E Zijlstra
Journal:  N Engl J Med       Date:  2007-12-13       Impact factor: 91.245

9.  Could proteomic research deliver the next generation of treatments for pneumococcal meningitis?

Authors:  U R Goonetilleke; S A Ward; S B Gordon
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-05-27

10.  Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses.

Authors:  Stephen B Gordon; Rose Malamba; Neema Mthunthama; Elizabeth R Jarman; Kondwani Jambo; Khuzwayo Jere; Eduard E Zijlstra; Malcolm E Molyneux; John Dennis; Neil French
Journal:  Vaccine       Date:  2008-08-15       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.